IMPORTANCE
PLCG2-associated antibody deficiency and immune dysregulation
(PLAID) is a newly characterized immunodeficiency syndrome associated with distinct
cutaneous features. Awareness of the cutaneous skin findings associated with PLAID may
facilitate diagnosis and improve patient care.
OBJECTIVES
To characterize the cutaneous manifestations of PLAID and identify potential
cellular mechanisms of the disease.
DESIGN, SETTING, AND PARTICIPANTS
In this retrospective analysis of patients with PLAID and PLAID-like disease
evaluated at the National Institutes of Health from January 1, 2005, through December
31, 2014, patients with deletions in PLCG2 leading to PLAID and
patients with PLAID-like disease for whom a PLAID mutation was not identified were
studied.
MAIN OUTCOMES AND MEASURES
Characterization of cutaneous manifestations of PLAID and PLAID-like disease
and analysis of PLAID immune cell activation.
RESULTS
Among 36 patients with PLAID and PLAID-like phenotypes, all of whom had
evaporative cold urticaria, 8 patients had a history of unique neonatal-onset ulcerative
and cutaneous lesions in cold-sensitive regions of the body. Granulomatous skin lesions
sparing warm regions (eg, flexural surfaces and skinfolds) were identified in 4
patients. Neutrophils and monocytes from patients with PLAID exhibited enhanced baseline
activation in vitro, which was potentiated by ambient temperature exposure.
CONCLUSIONS AND RELEVANCE
Collectively, these findings suggest that early identification of neonatal
lesions may help in the diagnosis of PLAID and that leukocyte hyperactivation may
underlie cutaneous lesions in patients with PLAID. Further characterization of
mechanisms underlying leukocyte hyperactivation may contribute to the fundamental
understanding of granuloma formation.